Who Wegovy may be suitable for
Wegovy is a once-weekly semaglutide injection. Semaglutide is a GLP-1 receptor agonist, which means it acts on pathways involved in appetite, fullness, glucose regulation and gastric emptying. In UK product information, Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for adults with a BMI of 30 kg/m2 or above, or a BMI of 27 kg/m2 to below 30 kg/m2 where at least one weight-related comorbidity is present. [1]
NICE recommends semaglutide for weight management only within specific NHS criteria and alongside multidisciplinary lifestyle support. The broader clinical point is important: Wegovy should not be approached as a stand-alone fix. It works best when prescribing, dose escalation, side-effect management, nutrition, activity and follow-up are treated as part of the same plan. [3][4]
For women, suitability also means checking reproductive plans, contraception, PCOS or menstrual concerns, diabetes medicines, previous gallbladder or pancreas problems, kidney risk from dehydration, eye disease in diabetes, mental health history, and any planned surgery or procedures requiring sedation.
Wegovy side effects in females: what is common and what needs action
The main side effects reported with Wegovy are not usually female-specific. The women's health issue is often how those side effects interact with everyday risks: dehydration, oral contraceptive absorption, pregnancy planning, PCOS, period changes, fertility treatment or anaemia from heavy bleeding.
In clinical trial information within the Wegovy SmPC, nausea, diarrhoea, vomiting and constipation were common and were most often reported during dose escalation. Most gastrointestinal events were mild to moderate, but some led to treatment discontinuation. [1]
|
Safety route
|
What you may notice
|
Why it matters
|
What to do
|
|
Monitor and self-manage
|
Mild nausea, constipation, diarrhoea, reduced appetite, indigestion, bloating or tiredness that is improving.
|
These are recognised Wegovy side effects and are often more noticeable while the dose is being increased.
|
Keep hydrated, eat smaller meals if helpful, avoid very rich meals if they worsen symptoms, and mention symptoms at your next review if they persist.
|
|
Contact your prescriber
|
Vomiting or diarrhoea that does not settle, symptoms that stop you drinking enough fluid, dizziness, worsening constipation, palpitations, worsening mood, new eye symptoms, or side effects that make you want to skip doses.
|
Dose-related side effects may need individual advice. Vomiting or diarrhoea can also affect hydration and, if you use the contraceptive pill, pill absorption.
|
Contact your prescriber or clinician before taking further doses if symptoms are severe, persistent, worsening or affecting daily life.
|
|
Seek urgent medical help
|
Persistent severe abdominal pain, pain spreading to the back, yellowing of the skin or eyes, dark urine, pale stools, fever, sudden vision loss, swelling of the throat or tongue, breathing difficulty, collapse, or signs of a severe allergic reaction.
|
These symptoms could suggest rare but serious problems such as pancreatitis, gallbladder complications, serious eye complications or anaphylaxis.
|
Seek urgent medical advice. Use 111, urgent care or 999 depending on severity. Do not wait for a routine review if symptoms are severe or rapidly worsening. [13][14][15]
|
Pregnancy, breastfeeding and contraception
Wegovy should not be used during pregnancy. The eMC patient leaflet advises contraception while using Wegovy and says treatment should be stopped at least 2 months before a planned pregnancy. MHRA patient guidance gives the same 2-month wash-out period for semaglutide medicines such as Wegovy, Ozempic and Rybelsus. [2][5]
If you become pregnant while using Wegovy, or think you might be pregnant, speak to a healthcare professional straight away. Do not make assumptions based on social media stories about 'Ozempic babies' or unexpected pregnancies. The safe action is to stop and get individual clinical advice. [2][5]
Wegovy should not be used while breastfeeding. UK product information states that a risk to a breast-fed child cannot be excluded, and MHRA patient guidance advises that GLP-1 medicines should not be taken by people who are breastfeeding because there is not enough safety data. [1][5]
Semaglutide is not anticipated to reduce the effectiveness of oral contraceptives based on clinical pharmacology data, and CoSRH patient information states there is currently no evidence that semaglutide reduces the effectiveness of the combined pill or progestogen-only pill.
However, vomiting within 3 hours of taking the pill, or severe diarrhoea for more than 24 hours, can reduce pill effectiveness. In that situation, follow missed-pill guidance and consider condoms or a non-oral method if symptoms persist. [1][7]
Fertility and planning to conceive
Some women may become more fertile as weight decreases, particularly if weight loss improves ovulation or menstrual regularity. This is especially relevant for women with PCOS, where weight management can improve some symptoms and may help restore ovulation in some cases. [9][10]
That does not mean Wegovy is a fertility treatment. The Wegovy SmPC states that the effect of semaglutide on fertility in humans is unknown. It also states that animal studies found reproductive toxicity and that semaglutide should be stopped at least 2 months before planned pregnancy. [1]
If you are trying to conceive, preparing for fertility treatment, or may want to become pregnant soon, discuss this before starting Wegovy. The right answer may be to delay treatment, choose another approach, or agree a clear stop date and contraception plan.
Wegovy and PCOS
PCOS is a hormonal condition that can involve irregular periods, excess androgen symptoms, insulin resistance, weight-management difficulty and fertility problems. NHS guidance says that for people with PCOS who are overweight, losing weight and eating a healthy, balanced diet can make some symptoms better. [9]
Wegovy may be relevant for some women with PCOS because it can support clinically supervised weight loss when they meet weight-management prescribing criteria. It should not be described as a direct treatment for PCOS, and it should not replace PCOS-specific care such as menstrual-cycle management, fertility assessment, contraception advice, diabetes-risk monitoring or treatment of excess hair growth and acne where needed.
The evidence for GLP-1 receptor agonists in PCOS is still developing. Systematic review evidence suggests GLP-1 receptor agonists can help reduce weight-related measures in women with PCOS and obesity, but the evidence for reproductive, psychological and long-term outcomes remains more limited than the evidence for weight loss. [10][12]
Can Wegovy affect your period?
Menstrual-cycle changes are a common search concern, but they need careful wording. Irregular periods or bleeding changes are not listed as one of the typical Wegovy adverse reactions in the SmPC adverse-reaction table. [1]
Some women notice period changes around the same time they start weight-loss treatment. That does not prove Wegovy is the cause. Periods can be affected by PCOS, weight change, calorie intake, stress, thyroid disease, perimenopause, contraception changes, pregnancy, miscarriage, anaemia, gynaecological conditions and other medicines.
If your periods become heavier, prolonged, painful, very irregular, or you have unexpected bleeding after sex or after menopause, speak to a GP or clinician. If pregnancy is possible, take a pregnancy test and contact a healthcare professional promptly if it is positive while you are using Wegovy.
What to check before starting Wegovy
Before starting Wegovy, a good consultation should do more than confirm your weight. For women, it should actively check the clinical points that could affect safety, suitability and monitoring.
- Whether you are pregnant, trying to become pregnant, breastfeeding, or planning pregnancy in the next few months.
- What contraception you use, whether vomiting or diarrhoea could affect your pill, and whether a non-oral option would be more reliable for you.
- Whether you have PCOS, irregular periods, heavy bleeding, fertility-treatment plans or concerns about ovulation.
- Whether you take insulin, sulfonylureas, warfarin or other medicines where monitoring may be needed. [1][6]
- Whether you have previous pancreatitis, gallbladder disease, severe gastroparesis, kidney problems, diabetic eye disease or planned surgery or sedation. [1][6]
- Whether you have a history of eating disorders, severe restriction, or weight-loss medication misuse.
How to get better results safely
Wegovy does not remove the need for practical structure. It can make appetite easier to manage for many people, but long-term results still depend on what happens around the medicine: protein intake, fibre, hydration, resistance training, sleep, alcohol intake, dose tolerance, side-effect management and realistic follow-up.
For women, resistance training is particularly useful because rapid weight loss can reduce lean mass as well as fat mass. A simple plan built around regular meals, protein at each meal, high-fibre foods, hydration and progressive strength work is usually more sustainable than aggressive restriction.
Do not increase your dose early, combine Wegovy with another GLP-1 medicine, restart after a long break, or change treatment because results feel slow without prescriber advice. The right dose is the dose that balances benefit, side effects and safety.
